Angiopoietin 1 Expression Levels in the Myocardium Direct Coronary Vessel Development

Developmental Dynamics

Volumn 229, Issue 3, 2004, Pages 500-509

  Ward, Nicome L ^a,d   Van Slyke, Paul ^b   Sturk, Celina ^b   Cruz, Maribelle ^a   Dumont, Daniel J ^a,b,c  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Conditional expression; Coronary vessels; Doxycycline; Heart; Tie2 Tek; Transgenic

Indexed keywords

ANGIOPOIETIN 1; NERVE CELL ADHESION MOLECULE;

ARTICLE; CELL CONTACT; CELL DEATH; CORONARY BLOOD VESSEL; EMBRYO; EPICARDIUM; GENOTYPE; HEART ATRIUM ENLARGEMENT; HEART DEVELOPMENT; HEART RIGHT VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSGENIC MOUSE;

ANGIOPOIETIN-1; ANIMALS; BLOTTING, WESTERN; CADHERINS; CORONARY VESSELS; DEVELOPMENTAL BIOLOGY; DOXYCYCLINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOTYPE; HEART; HEMORRHAGE; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MODELS, GENETIC; MYOCARDIUM; PERICARDIUM; PRECIPITIN TESTS; SIGNAL TRANSDUCTION; TIME FACTORS;

MUS MUSCULUS;

EID: 1542378240     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.10479     Document Type: Article

References (43)

1. Adams RH. 2002, Vascular patterning by Eph receptor tyrosine kinases and ephrins. Semin Cell Dev Biol 13:55-60.
2. Adams RH, Klein R. 2000. Eph receptors and ephrin ligands, essential mediators of vascular development. Trends Cardiovasc Med 10:183-188.
3. Bernanke DH, Velkey JM. 2002. Development of the coronary blood supply: changing concepts and current ideas. Anat Rec 269:198-208.
4. Betsholtz C, Karlsson L, Lindahl P. 2001. Developmental roles of platelet-derived growth factors. Bioessays 23:494-507.
5. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. 2002. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109:987-991.
6. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonplerre PC, Yancopoulos GD. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169.
7. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. 1992. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7:1471-1480.
8. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-1909.
9. Dyson E, Sucov HM, Kubalak SW, Schmid-Schonbein GW, DeLano FA, Evans RM, Ross J Jr, Chien KR. 1995. Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice. Proc Natl Acad Sci U S A 92:7386-7390.
10. Fishman MC, Chien KR. 1997. Fashioning the vertebrate heart: earliest embryonic decisions. Development 124:2099-2117.
11. Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, Ruiz-Lozano P, Gu Y, Nath AK, Huang Y, Hickey R, Dalton N, Peterson KL, Ross J Jr, Chien KR, Ferrara N. 2001. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 98:5780-5785.
12. Goncharova EJ, Kam Z, Geiger B. 1992. The involvement of adherens junction components in myofibrillogenesis in cultured cardiac myocytes. Development 114:173-183.
13. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J Jr, Lefkowitz RJ, Caron MG, Giros B. 1996. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A 93:12974-12979.
14. Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H, Daly R, Alitalo K, Dumont DJ. 1999. Identification of Tek/ Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274:30896-30905.
15. Jones N, Voskas D, Master Z, Sarao R, Jones J, Dumont DJ. 2001. Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2:438-445.
16. Kastner P, Grondona JM, Mark M, Gansmuller A, LeMeur M, Decimo D, Vonesch JL, Dolle P, Chambon P. 1994. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78:987-1003.
17. Kaufmann U, Martin B, Link D, Witt K, Zeitler R, Reinhard S, Starzinski-Powitz A. 1999. M-cadherin and its sisters in development of striated muscle. Cell Tissue Res 296:191-198.
18. Knudsen KA, Soler AP. 2000. Cadherin-mediated cell-cell interactions. Methods Mol Biol 137:409-440.
19. Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA, Labow MA. 1995. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121:489-503.
20. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:55-60.
21. Mikawa T. 1999. Cardiac lineages. In: Harvey RP, Rosenthal N, editors. Heart development. New York: Academic Press. p 19-33.
22. Miquerol L, Langille BL, Nagy A. 2000. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127:3941-3946.
23. Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A. 1999. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126:1845-1857.
24. Morabito CJ, Kattan J, Bristow J. 2002. Mechanisms of embryonic coronary artery development. Curr Opin Cardiol 17:235-241.
25. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y. 2002. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12:13-19.
26. Nguyen LL D'Amore PA. 2001. Cellular interactions in vascular growth and differentiation. Int Rev Cytol 204:1-48,
27. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY. 1999. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev 13:1037-1049.
28. Puri MC, Partanen J, Rossant J, Bernstein A. 1999. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 126:4569-4580.
29. Reese DE, Mikawa T, Bader DM. 2002. Development of the coronary vessel system. Circ Res 91:761-768.
30. Sarao R, Dumont DJ. 1998. Conditional transgene expression In endothelial cells. Transgenic research. 7:421-427.
31. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74.
32. Soler AP, Knudsen KA. 1994. N-cadherin involvement in cardiac myocyte interaction and myofibrillogenesis. Dev Biol 162:9-17.
33. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J. 1991. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 266:24613-24620.
34. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
35. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471.
36. Tevosian SG, Deconinck AE, Tanaka M, Schinke M, Litovsky SH, Izumo S, Fujiwara Y, Orkin SH. 2000. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 101:729-739.
37. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-2514.
38. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H, McClain J, Copeland NG, Gilbert DJ, Jenkins NA, Huang T, Papadopoulos N, Maisonpierre PC, Davis S, Yancopoulos GD. 1999. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A 96:1904-1909.
39. Velkkola T, Alitalo K. 1999. VEGFs, receptors and angiogenesis. Semin Cancer Biol 9:211-220.
40. Visconti RP, Richardson CD, Sato TN. 2002. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Scl U S A 99:8219-8224.
41. Wagner KD, Wagner N, Bondke A, Nafz B, Flemming B, Theres H, Scholz H. 2002. The Wilms' tumor suppressor Wtl is expressed in the coronary vasculature after myocardial infarction. FASEB J 16:1117-1119.
42. Yang JT, Rayburn H, Hynes RO. 1995. Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 121:549-560.
43. Yu Z, Redfern CS, Fishman GI. 1996. Conditional transgene expression in the heart. Circ Res 79:691-697.